| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J9271 |
Injection, pembrolizumab, 1 mg |
1,635 |
1,325 |
$11.84M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
60,923 |
58,286 |
$10.48M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
49,869 |
47,565 |
$9.11M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
46,796 |
40,492 |
$7.69M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
41,010 |
36,760 |
$7.11M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
29,408 |
24,953 |
$5.23M |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
67,035 |
62,824 |
$5.01M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
4,428 |
4,418 |
$4.94M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
20,507 |
17,412 |
$4.87M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
29,295 |
11,432 |
$4.18M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
21,524 |
20,179 |
$4.11M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
28,469 |
27,131 |
$4.10M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
60,727 |
57,890 |
$3.60M |
| 70450 |
Computed tomography, head or brain; without contrast material |
8,461 |
8,193 |
$2.75M |
| 93976 |
|
5,593 |
5,444 |
$2.61M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
17,217 |
6,734 |
$2.34M |
| G0378 |
Hospital observation service, per hour |
10,579 |
10,103 |
$2.32M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
9,445 |
9,264 |
$2.29M |
| 80053 |
Comprehensive metabolic panel |
117,489 |
102,628 |
$2.11M |
| 87486 |
|
60,857 |
58,092 |
$2.08M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
9,927 |
8,631 |
$1.90M |
| D0999 |
Unspecified diagnostic procedure, by report |
12,686 |
11,884 |
$1.88M |
| 76770 |
|
6,558 |
6,431 |
$1.85M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
11,069 |
6,598 |
$1.78M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
9,280 |
7,945 |
$1.76M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
46,269 |
43,933 |
$1.75M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
9,808 |
8,712 |
$1.74M |
| 90834 |
Psychotherapy, 45 minutes with patient |
11,117 |
5,461 |
$1.66M |
| 99215 |
Prolong outpt/office vis |
8,906 |
8,543 |
$1.65M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
4,470 |
4,457 |
$1.56M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
8,277 |
7,890 |
$1.42M |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
1,518 |
1,179 |
$1.41M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,692 |
1,692 |
$1.29M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
55,328 |
51,855 |
$1.27M |
| 96415 |
|
2,436 |
1,618 |
$1.24M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,203 |
2,197 |
$1.22M |
| 87581 |
|
60,871 |
58,086 |
$1.18M |
| 96367 |
|
10,855 |
8,529 |
$1.08M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
54,049 |
46,384 |
$1.06M |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
2,316 |
1,714 |
$1.01M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
34,872 |
32,205 |
$1.00M |
| 36430 |
|
2,728 |
2,101 |
$926K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,738 |
2,681 |
$922K |
| 36415 |
Collection of venous blood by venipuncture |
124,375 |
99,930 |
$867K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
616 |
616 |
$768K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
34,851 |
32,196 |
$761K |
| 12001 |
|
1,662 |
1,655 |
$749K |
| 97162 |
|
4,365 |
4,340 |
$712K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
21,954 |
21,756 |
$692K |
| 92567 |
|
5,799 |
5,777 |
$689K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
2,033 |
2,015 |
$684K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,704 |
1,666 |
$678K |
| 12011 |
|
1,509 |
1,490 |
$667K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
1,871 |
1,298 |
$626K |
| 70498 |
|
1,934 |
1,907 |
$618K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
11,685 |
5,219 |
$610K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,443 |
2,397 |
$606K |
| 77386 |
|
5,867 |
582 |
$556K |
| 95782 |
|
695 |
695 |
$539K |
| 97161 |
|
3,710 |
3,687 |
$529K |
| 12002 |
|
1,061 |
1,049 |
$480K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
729 |
729 |
$474K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,904 |
3,888 |
$473K |
| 90791 |
Psychiatric diagnostic evaluation |
1,887 |
1,860 |
$447K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,564 |
2,438 |
$435K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
3,591 |
1,895 |
$425K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,970 |
1,968 |
$418K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
7,917 |
7,671 |
$411K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
10,766 |
9,324 |
$406K |
| 87536 |
|
4,839 |
4,773 |
$401K |
| 90836 |
|
4,619 |
2,324 |
$387K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
6,223 |
6,217 |
$386K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
20,125 |
19,352 |
$371K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,806 |
1,797 |
$368K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
11,891 |
8,624 |
$368K |
| Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
229 |
135 |
$352K |
| 86850 |
|
16,160 |
14,710 |
$350K |
| 59025 |
Fetal non-stress test |
1,560 |
1,255 |
$340K |
| 84443 |
Thyroid stimulating hormone (TSH) |
44,682 |
43,086 |
$332K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,633 |
1,627 |
$331K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,071 |
1,066 |
$327K |
| 82803 |
|
16,086 |
14,385 |
$326K |
| 70491 |
|
1,223 |
1,205 |
$314K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,498 |
818 |
$311K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,412 |
1,831 |
$307K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
132,439 |
116,369 |
$302K |
| 86901 |
|
16,531 |
14,380 |
$299K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,489 |
1,483 |
$299K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
12,409 |
10,615 |
$297K |
| 10060 |
|
841 |
828 |
$290K |
| 97116 |
|
3,164 |
1,543 |
$289K |
| 96417 |
|
3,311 |
2,122 |
$280K |
| 88185 |
|
1,956 |
1,433 |
$279K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,059 |
846 |
$268K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
32,281 |
31,909 |
$265K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,801 |
1,692 |
$262K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
2,393 |
1,666 |
$252K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
19,029 |
16,632 |
$252K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
9,010 |
9,004 |
$251K |
| 80061 |
Lipid panel |
24,633 |
24,447 |
$248K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,176 |
1,172 |
$244K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
233 |
233 |
$241K |
| 70486 |
|
2,248 |
2,217 |
$234K |
| 92526 |
|
1,528 |
913 |
$230K |
| 74183 |
|
699 |
698 |
$220K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,649 |
1,649 |
$220K |
| 86900 |
|
16,559 |
14,404 |
$219K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
7,625 |
7,502 |
$212K |
| 14040 |
|
171 |
171 |
$211K |
| 80076 |
|
18,301 |
17,342 |
$207K |
| J9035 |
Injection, bevacizumab, 10 mg |
54 |
38 |
$206K |
| Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg |
240 |
131 |
$204K |
| G0390 |
Trauma response team associated with hospital critical care service |
114 |
114 |
$202K |
| 99205 |
Prolong outpt/office vis |
1,012 |
1,010 |
$202K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,573 |
2,313 |
$201K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
9,050 |
8,095 |
$195K |
| 76830 |
Ultrasound, transvaginal |
5,729 |
5,614 |
$193K |
| 83880 |
|
5,198 |
4,317 |
$192K |
| 77336 |
|
2,837 |
1,396 |
$191K |
| 54161 |
|
265 |
265 |
$190K |
| 94060 |
|
2,658 |
2,642 |
$184K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,643 |
3,488 |
$182K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
928 |
928 |
$181K |
| 36591 |
|
7,328 |
4,734 |
$181K |
| 86235 |
|
9,701 |
5,024 |
$180K |
| 84439 |
|
21,614 |
21,032 |
$174K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12,620 |
12,529 |
$173K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,297 |
4,240 |
$169K |
| 96416 |
|
312 |
197 |
$169K |
| J1437 |
Injection, ferric derisomaltose, 10 mg |
417 |
401 |
$169K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
3,147 |
2,660 |
$168K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
7,940 |
7,875 |
$167K |
| 77334 |
|
1,109 |
912 |
$167K |
| 97535 |
Self-care/home management training, each 15 minutes |
2,158 |
1,740 |
$167K |
| 80047 |
|
6,991 |
6,748 |
$167K |
| 93970 |
|
288 |
282 |
$164K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
800 |
796 |
$164K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
2,770 |
744 |
$158K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,054 |
2,998 |
$156K |
| 54640 |
|
151 |
151 |
$155K |
| 71250 |
|
1,636 |
1,626 |
$155K |
| 87088 |
|
27,467 |
25,392 |
$154K |
| 92587 |
|
3,171 |
3,161 |
$153K |
| 86481 |
|
3,392 |
3,367 |
$151K |
| J1756 |
Injection, iron sucrose, 1 mg |
3,220 |
1,652 |
$150K |
| 97166 |
|
1,307 |
1,298 |
$148K |
| 72141 |
|
452 |
450 |
$147K |
| 92610 |
|
1,034 |
1,029 |
$146K |
| 87660 |
|
12,893 |
12,544 |
$143K |
| 82728 |
|
15,864 |
14,890 |
$143K |
| 97163 |
|
715 |
713 |
$142K |
| 83655 |
|
11,040 |
10,982 |
$142K |
| 90651 |
|
1,001 |
997 |
$142K |
| 70496 |
|
1,783 |
1,755 |
$140K |
| 40806 |
|
124 |
124 |
$139K |
| 44970 |
|
64 |
64 |
$137K |
| 86780 |
|
15,558 |
15,145 |
$137K |
| 92557 |
|
2,124 |
2,108 |
$137K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
2,516 |
2,020 |
$136K |
| 87480 |
|
12,425 |
12,088 |
$136K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,483 |
5,396 |
$135K |
| 81229 |
|
109 |
108 |
$134K |
| 83970 |
|
3,074 |
2,968 |
$130K |
| 86003 |
|
3,716 |
1,812 |
$129K |
| 87510 |
|
11,947 |
11,625 |
$129K |
| 86480 |
|
2,401 |
2,373 |
$128K |
| 92551 |
|
2,011 |
2,009 |
$127K |
| 84702 |
|
29,949 |
26,193 |
$126K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
551 |
414 |
$119K |
| 99407 |
|
1,307 |
1,075 |
$116K |
| 72156 |
|
370 |
368 |
$114K |
| 96158 |
|
1,388 |
1,178 |
$114K |
| 85027 |
|
41,488 |
35,595 |
$111K |
| 99442 |
|
875 |
849 |
$110K |
| D0120 |
Periodic oral evaluation - established patient |
6,927 |
5,686 |
$110K |
| 93971 |
|
1,337 |
1,316 |
$109K |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
71 |
61 |
$109K |
| 83516 |
|
3,087 |
1,687 |
$107K |
| 96156 |
|
618 |
526 |
$107K |
| 96368 |
|
2,701 |
2,362 |
$106K |
| 90715 |
|
4,006 |
3,983 |
$105K |
| 82947 |
|
40,077 |
31,216 |
$104K |
| 76801 |
|
1,794 |
1,713 |
$103K |
| 77065 |
Tomosynthesis, mammo |
1,386 |
1,349 |
$102K |
| 76942 |
|
621 |
607 |
$100K |
| 72131 |
|
1,587 |
1,567 |
$100K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
34,905 |
31,356 |
$99K |
| 82607 |
|
9,511 |
9,386 |
$98K |
| 76642 |
|
2,243 |
2,209 |
$95K |
| 16020 |
|
203 |
195 |
$94K |
| 84403 |
|
4,330 |
4,153 |
$93K |
| 31575 |
|
666 |
659 |
$92K |
| 71046 |
Radiologic examination, chest; 2 views |
14,906 |
14,507 |
$90K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,181 |
2,178 |
$89K |
| 29125 |
|
366 |
358 |
$89K |
| D1110 |
Prophylaxis - adult |
5,181 |
3,676 |
$87K |
| 97165 |
|
1,153 |
1,141 |
$85K |
| 41010 |
|
108 |
108 |
$85K |
| 96040 |
|
2,258 |
2,230 |
$85K |
| 88342 |
|
1,999 |
1,920 |
$84K |
| 82784 |
|
9,655 |
7,448 |
$83K |
| 41115 |
|
80 |
80 |
$83K |
| 86803 |
|
11,116 |
11,045 |
$82K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
403 |
403 |
$82K |
| 87507 |
|
1,074 |
1,061 |
$82K |
| 76937 |
|
510 |
501 |
$81K |
| 87077 |
|
15,099 |
11,967 |
$81K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
6,231 |
6,222 |
$81K |
| 81003 |
|
60,877 |
47,973 |
$81K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
3,844 |
3,565 |
$80K |
| 36561 |
|
72 |
72 |
$80K |
| D9999 |
Unspecified adjunctive procedure, by report |
464 |
429 |
$79K |
| J0897 |
Injection, denosumab, 1 mg |
90 |
87 |
$79K |
| 77300 |
|
747 |
686 |
$79K |
| 87806 |
|
4,215 |
4,195 |
$78K |
| 90686 |
|
4,365 |
4,340 |
$77K |
| 85610 |
|
19,570 |
17,089 |
$77K |
| 95816 |
|
1,565 |
1,562 |
$75K |
| 87340 |
|
9,433 |
9,359 |
$75K |
| 72197 |
|
210 |
210 |
$74K |
| 97803 |
|
3,702 |
3,508 |
$74K |
| 76641 |
|
1,816 |
1,811 |
$73K |
| 92523 |
|
334 |
333 |
$72K |
| 88307 |
|
990 |
927 |
$71K |
| 95812 |
|
1,917 |
1,912 |
$70K |
| 86160 |
|
7,490 |
3,849 |
$69K |
| 77049 |
|
187 |
187 |
$68K |
| 82570 |
|
15,413 |
13,722 |
$68K |
| 88112 |
|
1,278 |
1,220 |
$67K |
| 77001 |
|
241 |
235 |
$67K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
311 |
310 |
$66K |
| 92579 |
|
1,022 |
1,021 |
$66K |
| 87522 |
Neg quan hep c or qual rna |
1,551 |
1,481 |
$66K |
| 86360 |
|
1,905 |
1,878 |
$65K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,638 |
1,034 |
$62K |
| 84202 |
|
6,613 |
6,463 |
$60K |
| 96409 |
|
882 |
628 |
$60K |
| 77066 |
Tomosynthesis, mammo |
921 |
917 |
$59K |
| 88304 |
|
2,376 |
2,310 |
$58K |
| 86902 |
|
1,590 |
1,077 |
$57K |
| 20610 |
|
233 |
209 |
$57K |
| 72128 |
|
1,303 |
1,291 |
$57K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,440 |
1,425 |
$57K |
| 74174 |
|
244 |
239 |
$56K |
| 86920 |
|
1,531 |
1,128 |
$55K |
| 83540 |
|
15,141 |
14,575 |
$54K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
17,041 |
15,892 |
$53K |
| 99443 |
|
634 |
608 |
$53K |
| 83735 |
|
18,819 |
14,285 |
$53K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
391 |
374 |
$53K |
| 81001 |
|
21,408 |
19,668 |
$52K |
| 83550 |
|
14,857 |
14,305 |
$52K |
| 86618 |
|
5,187 |
3,198 |
$51K |
| 82670 |
|
2,292 |
2,246 |
$51K |
| 92582 |
|
806 |
805 |
$51K |
| 76536 |
|
1,599 |
1,588 |
$50K |
| 96411 |
|
1,874 |
1,233 |
$49K |
| 96112 |
|
289 |
288 |
$48K |
| 86762 |
|
3,669 |
3,630 |
$48K |
| 86140 |
|
21,608 |
20,633 |
$47K |
| 95811 |
|
65 |
65 |
$47K |
| 74178 |
|
345 |
344 |
$46K |
| 86923 |
|
1,383 |
853 |
$46K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,528 |
1,008 |
$46K |
| 85652 |
|
27,004 |
26,152 |
$44K |
| 97802 |
|
1,704 |
1,697 |
$44K |
| 96450 |
|
66 |
49 |
$44K |
| 62270 |
|
128 |
118 |
$43K |
| 83021 |
|
2,168 |
2,138 |
$43K |
| 84146 |
|
2,194 |
2,124 |
$42K |
| 69210 |
|
747 |
725 |
$42K |
| 88341 |
|
1,103 |
928 |
$41K |
| 25605 |
|
84 |
84 |
$41K |
| 83001 |
|
2,424 |
2,403 |
$40K |
| 84402 |
|
1,816 |
1,770 |
$40K |
| 82746 |
|
4,330 |
4,272 |
$39K |
| 76857 |
|
860 |
800 |
$39K |
| 87529 |
|
1,351 |
754 |
$39K |
| 86356 |
|
1,397 |
1,380 |
$38K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
175 |
173 |
$38K |
| 95886 |
|
271 |
269 |
$37K |
| 84153 |
|
2,722 |
2,624 |
$37K |
| 19083 |
|
25 |
24 |
$36K |
| 86359 |
|
1,889 |
1,864 |
$36K |
| 83002 |
|
2,052 |
2,015 |
$36K |
| 88184 |
|
1,475 |
1,379 |
$36K |
| 40819 |
|
41 |
41 |
$35K |
| 87501 |
|
907 |
904 |
$35K |
| 86038 |
|
7,316 |
7,279 |
$35K |
| 94760 |
|
5,411 |
4,362 |
$34K |
| 80197 |
|
3,611 |
2,261 |
$33K |
| 71045 |
Radiologic examination, chest; single view |
14,021 |
13,333 |
$33K |
| 76870 |
|
1,534 |
1,499 |
$33K |
| 77080 |
|
613 |
606 |
$32K |
| 72157 |
|
111 |
111 |
$32K |
| 84156 |
|
9,407 |
8,090 |
$32K |
| 86706 |
|
4,137 |
4,101 |
$31K |
| 99173 |
|
1,371 |
1,370 |
$31K |
| 85007 |
|
24,445 |
20,068 |
$30K |
| 87205 |
|
15,976 |
15,298 |
$30K |
| 82043 |
|
5,987 |
5,960 |
$30K |
| 82533 |
|
2,016 |
1,632 |
$30K |
| 86147 |
|
3,037 |
1,462 |
$30K |
| 47562 |
|
12 |
12 |
$30K |
| 86376 |
|
2,192 |
2,179 |
$30K |
| 87186 |
|
7,696 |
7,208 |
$30K |
| D0330 |
Panoramic radiographic image |
1,447 |
1,005 |
$29K |
| 87070 |
|
5,791 |
5,479 |
$29K |
| 84100 |
|
10,956 |
8,595 |
$29K |
| 92553 |
|
392 |
392 |
$29K |
| 95819 |
|
632 |
631 |
$29K |
| 77062 |
|
556 |
555 |
$28K |
| 77412 |
|
447 |
52 |
$28K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
287 |
102 |
$28K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
21,417 |
17,475 |
$28K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,111 |
2,047 |
$28K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
10,169 |
6,778 |
$28K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
62 |
38 |
$27K |
| 87641 |
|
1,320 |
1,302 |
$27K |
| 84484 |
|
20,334 |
14,741 |
$26K |
| 84207 |
|
994 |
978 |
$26K |
| 76882 |
|
764 |
733 |
$26K |
| 83690 |
|
19,808 |
18,562 |
$26K |
| 87640 |
|
1,322 |
1,305 |
$26K |
| 82565 |
|
5,816 |
5,713 |
$26K |
| 93351 |
|
195 |
192 |
$26K |
| 86787 |
|
3,294 |
3,232 |
$25K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
1,868 |
1,867 |
$25K |
| 87150 |
|
710 |
708 |
$25K |
| 74420 |
|
123 |
118 |
$25K |
| 80069 |
|
2,291 |
2,141 |
$25K |
| 92522 |
|
106 |
106 |
$24K |
| 86225 |
|
5,334 |
5,286 |
$24K |
| 85730 |
|
9,242 |
8,723 |
$24K |
| 88237 |
|
241 |
240 |
$24K |
| 74018 |
|
5,438 |
5,223 |
$24K |
| 86146 |
|
2,756 |
1,367 |
$24K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
7,863 |
7,582 |
$23K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
71 |
70 |
$23K |
| 94726 |
|
1,241 |
1,232 |
$23K |
| 82010 |
|
2,259 |
1,962 |
$23K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
3,249 |
2,036 |
$23K |
| 84305 |
|
1,152 |
1,140 |
$22K |
| D0140 |
Limited oral evaluation - problem focused |
1,272 |
1,127 |
$22K |
| 70487 |
|
65 |
65 |
$21K |
| 86141 |
|
2,123 |
2,104 |
$21K |
| 77061 |
|
530 |
528 |
$21K |
| 96402 |
|
390 |
373 |
$21K |
| 73130 |
|
3,811 |
3,726 |
$21K |
| 90677 |
|
769 |
766 |
$21K |
| 86431 |
|
4,411 |
4,395 |
$20K |
| 54163 |
|
27 |
27 |
$20K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
2,165 |
1,360 |
$20K |
| 84550 |
|
5,111 |
4,847 |
$20K |
| 86200 |
|
857 |
855 |
$20K |
| 51798 |
|
92 |
88 |
$20K |
| 97164 |
|
152 |
150 |
$20K |
| 95715 |
|
92 |
64 |
$20K |
| 84460 |
|
4,633 |
4,542 |
$20K |
| 82785 |
|
1,921 |
1,862 |
$20K |
| 92504 |
|
621 |
523 |
$20K |
| 87497 |
|
694 |
490 |
$19K |
| 83615 |
|
5,826 |
5,265 |
$19K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
30 |
30 |
$19K |
| 88271 |
|
385 |
246 |
$19K |
| 49083 |
|
27 |
13 |
$18K |
| 84425 |
|
1,728 |
1,712 |
$18K |
| 51600 |
|
43 |
42 |
$18K |
| 87210 |
|
9,085 |
6,870 |
$18K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
84 |
84 |
$18K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,028 |
1,022 |
$18K |
| 94729 |
|
1,764 |
1,752 |
$18K |
| 87081 |
|
4,046 |
3,748 |
$17K |
| 86704 |
|
2,161 |
2,145 |
$17K |
| 96136 |
|
150 |
150 |
$17K |
| 86800 |
|
1,337 |
1,324 |
$17K |
| 84450 |
|
4,170 |
4,085 |
$17K |
| 73630 |
|
3,409 |
3,352 |
$17K |
| 87184 |
|
4,276 |
4,036 |
$16K |
| 86039 |
|
3,172 |
3,156 |
$16K |
| 86769 |
|
460 |
451 |
$16K |
| J9045 |
Injection, carboplatin, 50 mg |
1,214 |
759 |
$16K |
| 84481 |
|
1,928 |
1,891 |
$15K |
| 83605 |
|
14,465 |
12,611 |
$15K |
| 97113 |
|
112 |
59 |
$15K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
205 |
94 |
$15K |
| 82627 |
|
681 |
677 |
$15K |
| 87338 |
|
1,707 |
1,699 |
$15K |
| 72100 |
|
1,824 |
1,806 |
$15K |
| 80074 |
|
653 |
652 |
$14K |
| 86665 |
|
1,604 |
820 |
$14K |
| 71271 |
|
602 |
601 |
$14K |
| 96523 |
|
140 |
129 |
$14K |
| 85576 |
|
428 |
380 |
$14K |
| 73610 |
|
3,196 |
3,098 |
$14K |
| 73564 |
|
2,806 |
2,764 |
$14K |
| 91322 |
|
188 |
188 |
$14K |
| 11721 |
|
408 |
321 |
$13K |
| 99153 |
Mod sedat endo service >5yrs |
1,424 |
1,386 |
$13K |
| 73030 |
|
2,762 |
2,667 |
$13K |
| 86334 |
|
859 |
844 |
$13K |
| 83520 |
|
513 |
324 |
$13K |
| 73590 |
|
2,406 |
2,317 |
$13K |
| 82550 |
|
4,176 |
3,939 |
$13K |
| 73110 |
|
2,787 |
2,687 |
$12K |
| 88275 |
|
141 |
109 |
$12K |
| 87040 |
|
7,702 |
5,095 |
$12K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
658 |
656 |
$12K |
| 51700 |
|
53 |
37 |
$12K |
| 88108 |
|
264 |
222 |
$12K |
| 87625 |
|
481 |
481 |
$12K |
| 72158 |
|
39 |
39 |
$12K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
311 |
291 |
$11K |
| 43235 |
|
19 |
19 |
$11K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,542 |
1,388 |
$11K |
| D1120 |
Prophylaxis - child |
1,853 |
1,725 |
$11K |
| 82977 |
|
3,287 |
2,958 |
$11K |
| 82378 |
|
2,337 |
1,785 |
$11K |
| D0230 |
Intraoral - periapical each additional radiographic image |
1,817 |
1,553 |
$11K |
| 80177 |
|
1,858 |
1,718 |
$11K |
| 54830 |
|
50 |
50 |
$10K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
614 |
540 |
$10K |
| 80329 |
|
6,871 |
3,508 |
$10K |
| 72146 |
|
37 |
37 |
$10K |
| 12013 |
|
25 |
25 |
$10K |
| 77338 |
|
43 |
41 |
$10K |
| 83498 |
|
392 |
380 |
$10K |
| 87634 |
|
506 |
500 |
$10K |
| 73090 |
|
2,576 |
2,436 |
$10K |
| 96137 |
|
149 |
149 |
$10K |
| 83521 |
|
1,346 |
670 |
$10K |
| 92585 |
|
55 |
53 |
$10K |
| 80348 |
|
1,974 |
1,102 |
$10K |
| 84480 |
|
1,693 |
1,657 |
$10K |
| 90656 |
|
618 |
618 |
$10K |
| 84165 |
|
1,575 |
1,548 |
$10K |
| 83010 |
|
1,099 |
1,034 |
$10K |
| V2632 |
Posterior chamber intraocular lens |
165 |
12 |
$9K |
| 82105 |
|
1,689 |
1,595 |
$9K |
| 0124A |
|
258 |
258 |
$9K |
| 94010 |
|
636 |
628 |
$9K |
| 95806 |
|
174 |
174 |
$9K |
| 82248 |
|
2,391 |
2,144 |
$9K |
| 86765 |
|
859 |
843 |
$9K |
| 72040 |
|
1,347 |
1,321 |
$9K |
| 80164 |
|
1,282 |
1,170 |
$9K |
| Q3014 |
Telehealth originating site facility fee |
1,328 |
1,188 |
$9K |
| 36000 |
|
293 |
282 |
$8K |
| 95700 |
|
100 |
100 |
$8K |
| 88173 |
|
463 |
379 |
$8K |
| 73080 |
|
2,198 |
2,151 |
$8K |
| 77075 |
|
77 |
75 |
$8K |
| 86682 |
|
48 |
46 |
$8K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
118 |
25 |
$8K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
195 |
123 |
$8K |
| 80320 |
|
5,543 |
5,118 |
$8K |
| 85613 |
|
1,082 |
577 |
$8K |
| 77301 |
|
41 |
40 |
$8K |
| 83921 |
|
401 |
400 |
$7K |
| 90480 |
|
245 |
245 |
$7K |
| 74019 |
|
1,210 |
1,171 |
$7K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
25 |
25 |
$7K |
| 90670 |
|
370 |
368 |
$7K |
| 92134 |
|
483 |
453 |
$7K |
| 86355 |
|
304 |
244 |
$7K |
| 85378 |
|
3,545 |
3,440 |
$7K |
| 85732 |
|
1,187 |
1,185 |
$7K |
| 76885 |
|
316 |
316 |
$7K |
| 82150 |
|
2,701 |
2,554 |
$6K |
| 99384 |
|
30 |
30 |
$6K |
| 76978 |
|
12 |
12 |
$6K |
| 73502 |
|
1,130 |
1,106 |
$6K |
| 86255 |
|
1,142 |
943 |
$6K |
| 99152 |
|
2,026 |
1,983 |
$6K |
| 77470 |
|
89 |
89 |
$6K |
| 82247 |
|
1,341 |
1,201 |
$6K |
| 85245 |
|
291 |
274 |
$6K |
| 83020 |
|
609 |
520 |
$6K |
| 85044 |
|
5,048 |
4,172 |
$6K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
16 |
12 |
$6K |
| 85014 |
|
6,929 |
6,723 |
$6K |
| D0220 |
Intraoral - periapical first radiographic image |
3,007 |
2,941 |
$6K |
| 99383 |
|
26 |
26 |
$6K |
| 86664 |
|
764 |
758 |
$6K |
| 96401 |
|
104 |
55 |
$5K |
| 99170 |
|
24 |
24 |
$5K |
| 90750 |
|
40 |
40 |
$5K |
| J9267 |
Injection, paclitaxel, 1 mg |
268 |
142 |
$5K |
| 96150 |
|
41 |
34 |
$5K |
| 86705 |
|
946 |
904 |
$5K |
| 84154 |
|
547 |
522 |
$5K |
| 84155 |
|
1,739 |
1,706 |
$5K |
| D0274 |
Bitewings - four radiographic images |
2,287 |
2,203 |
$5K |
| 86708 |
|
807 |
803 |
$5K |
| 86870 |
|
215 |
161 |
$5K |
| 77295 |
|
13 |
12 |
$5K |
| 88142 |
|
212 |
212 |
$5K |
| 90713 |
|
188 |
187 |
$5K |
| 99441 |
|
83 |
78 |
$5K |
| 85246 |
|
344 |
331 |
$5K |
| 90697 |
|
197 |
197 |
$5K |
| 64642 |
|
78 |
12 |
$5K |
| 70543 |
|
12 |
12 |
$5K |
| 73562 |
|
454 |
452 |
$5K |
| 73060 |
|
1,339 |
1,297 |
$5K |
| 93270 |
|
67 |
67 |
$4K |
| 90680 |
|
541 |
540 |
$4K |
| 96130 |
|
74 |
74 |
$4K |
| 54360 |
|
12 |
12 |
$4K |
| C1769 |
Guide wire |
2,270 |
2,177 |
$4K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
138 |
132 |
$4K |
| 86735 |
|
693 |
671 |
$4K |
| 84703 |
|
4,905 |
4,800 |
$4K |
| J9370 |
Vincristine sulfate, 1 mg |
678 |
453 |
$4K |
| 93017 |
|
110 |
110 |
$4K |
| 97167 |
|
25 |
25 |
$4K |
| 87517 |
|
27 |
27 |
$4K |
| 83993 |
|
414 |
411 |
$4K |
| 85240 |
|
360 |
339 |
$4K |
| 86709 |
|
773 |
766 |
$4K |
| 87799 |
|
110 |
79 |
$4K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
6,509 |
6,328 |
$4K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
235 |
198 |
$4K |
| 90620 |
|
87 |
87 |
$4K |
| 80175 |
|
558 |
534 |
$4K |
| G0379 |
Direct admission of patient for hospital observation care |
76 |
75 |
$4K |
| 94664 |
|
2,029 |
1,392 |
$4K |
| 96151 |
|
29 |
24 |
$4K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
39 |
38 |
$4K |
| 73700 |
|
14 |
14 |
$4K |
| 82330 |
|
1,142 |
1,054 |
$4K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
139 |
90 |
$3K |
| 90734 |
|
130 |
130 |
$3K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
867 |
848 |
$3K |
| 73552 |
|
1,166 |
1,146 |
$3K |
| 90716 |
|
185 |
185 |
$3K |
| 95885 |
|
109 |
107 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
639 |
632 |
$3K |
| 74455 |
|
15 |
15 |
$3K |
| 46600 |
|
119 |
119 |
$3K |
| P9045 |
Infusion, albumin (human), 5%, 250 ml |
18 |
14 |
$3K |
| 77072 |
|
286 |
286 |
$3K |
| 90633 |
|
270 |
270 |
$3K |
| 99385 |
|
14 |
14 |
$3K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
14 |
14 |
$3K |
| 84436 |
|
872 |
866 |
$3K |
| J9070 |
Cyclophosphamide, 100 mg |
25 |
12 |
$3K |
| 72170 |
|
805 |
801 |
$3K |
| 0002A |
|
182 |
182 |
$3K |
| 83721 |
|
165 |
165 |
$3K |
| 84590 |
|
254 |
254 |
$3K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
396 |
276 |
$3K |
| 96113 |
|
46 |
46 |
$3K |
| 85384 |
|
1,160 |
1,040 |
$2K |
| 80183 |
|
350 |
339 |
$2K |
| 82024 |
|
37 |
37 |
$2K |
| 81025 |
|
742 |
725 |
$2K |
| D7140 |
Extraction, erupted tooth or exposed root |
112 |
83 |
$2K |
| 88300 |
|
1,099 |
1,052 |
$2K |
| 85660 |
|
194 |
151 |
$2K |
| 86162 |
|
130 |
126 |
$2K |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
38 |
38 |
$2K |
| 78306 |
|
39 |
39 |
$2K |
| 0001A |
|
167 |
167 |
$2K |
| 82140 |
|
375 |
340 |
$2K |
| 82172 |
|
150 |
149 |
$2K |
| 96376 |
|
3,787 |
3,143 |
$2K |
| 74230 |
|
28 |
28 |
$2K |
| 72070 |
|
429 |
426 |
$2K |
| 86696 |
|
142 |
131 |
$2K |
| 90746 |
|
94 |
94 |
$2K |
| 73560 |
|
449 |
444 |
$2K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
107 |
70 |
$2K |
| 86617 |
|
187 |
143 |
$2K |
| 82951 |
|
199 |
197 |
$2K |
| 86304 |
|
239 |
197 |
$2K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
13 |
13 |
$1K |
| J9190 |
Injection, fluorouracil, 500 mg |
137 |
92 |
$1K |
| 90707 |
|
100 |
100 |
$1K |
| J2785 |
Injection, regadenoson, 0.1 mg |
12 |
12 |
$1K |
| 84681 |
|
93 |
91 |
$1K |
| 0012A |
|
91 |
91 |
$1K |
| 86256 |
|
25 |
25 |
$1K |
| 82525 |
|
145 |
142 |
$1K |
| 86880 |
|
78 |
67 |
$1K |
| 90662 |
|
178 |
176 |
$1K |
| 86592 |
|
889 |
875 |
$1K |
| 78264 |
|
51 |
51 |
$1K |
| 81243 |
|
12 |
12 |
$1K |
| 86357 |
|
54 |
54 |
$1K |
| 87102 |
|
356 |
295 |
$1K |
| 84446 |
|
80 |
80 |
$1K |
| 82157 |
|
44 |
42 |
$1K |
| 82103 |
|
110 |
102 |
$1K |
| 86341 |
|
107 |
72 |
$1K |
| 87468 |
|
31 |
31 |
$1K |
| 86812 |
|
16 |
16 |
$1K |
| 87116 |
|
222 |
170 |
$1K |
| 99406 |
|
12 |
12 |
$1K |
| 97804 |
|
64 |
64 |
$1K |
| 92083 |
|
66 |
65 |
$1K |
| 0004A |
|
77 |
77 |
$1K |
| 86308 |
|
901 |
899 |
$1K |
| 84630 |
|
175 |
174 |
$959.62 |
| 92133 |
|
54 |
54 |
$952.12 |
| 84166 |
|
121 |
119 |
$934.15 |
| 0011A |
|
68 |
68 |
$933.07 |
| J3489 |
Injection, zoledronic acid, 1 mg |
95 |
93 |
$922.77 |
| 77290 |
|
14 |
14 |
$877.68 |
| 93299 |
|
40 |
40 |
$861.20 |
| 87147 |
|
367 |
360 |
$861.05 |
| 86148 |
|
151 |
79 |
$791.02 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
740 |
699 |
$787.82 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
3,148 |
3,099 |
$745.47 |
| C1729 |
Catheter, drainage |
1,370 |
1,139 |
$730.86 |
| J2704 |
Injection, propofol, 10 mg |
8,272 |
8,046 |
$729.91 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,512 |
2,231 |
$723.99 |
| 0054A |
|
61 |
59 |
$698.33 |
| 87177 |
|
101 |
98 |
$671.28 |
| 86301 |
|
112 |
86 |
$669.66 |
| 86364 |
|
96 |
92 |
$645.40 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
564 |
562 |
$636.20 |
| 86300 |
|
68 |
38 |
$634.54 |
| 73070 |
|
218 |
210 |
$599.86 |
| 87469 |
|
31 |
31 |
$590.63 |
| 87478 |
|
31 |
31 |
$590.63 |
| 87484 |
|
31 |
31 |
$590.63 |
| 98960 |
|
15 |
15 |
$587.31 |
| 87073 |
|
135 |
119 |
$583.31 |
| 73100 |
|
197 |
191 |
$575.59 |
| 87181 |
|
118 |
69 |
$570.93 |
| J1610 |
Injection, glucagon hydrochloride, per 1 mg |
12 |
12 |
$565.06 |
| 90671 |
|
190 |
190 |
$562.15 |
| G0008 |
Administration of influenza virus vaccine |
323 |
320 |
$560.45 |
| 82274 |
|
389 |
381 |
$549.83 |
| 87206 |
|
218 |
170 |
$539.50 |
| 87015 |
|
332 |
255 |
$489.77 |
| 99217 |
|
25 |
25 |
$484.14 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
296 |
293 |
$477.19 |
| 82390 |
|
64 |
64 |
$456.92 |
| 73140 |
|
168 |
166 |
$440.79 |
| 84145 |
|
1,076 |
1,029 |
$424.23 |
| 77280 |
|
14 |
12 |
$404.11 |
| 87209 |
|
83 |
81 |
$379.98 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
6,958 |
6,246 |
$378.04 |
| 86922 |
|
18 |
13 |
$375.30 |
| 90632 |
|
12 |
12 |
$370.10 |
| 82653 |
|
27 |
27 |
$362.90 |
| 82787 |
|
29 |
15 |
$359.76 |
| 84134 |
|
58 |
55 |
$358.36 |
| 86335 |
|
13 |
13 |
$347.01 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
8,608 |
7,994 |
$339.19 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,921 |
1,770 |
$299.98 |
| 76820 |
|
26 |
12 |
$296.90 |
| 82952 |
|
199 |
197 |
$294.48 |
| J9250 |
Methotrexate sodium, 5 mg |
171 |
123 |
$291.71 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14,742 |
13,327 |
$288.42 |
| 72110 |
|
14 |
14 |
$284.66 |
| 73120 |
|
67 |
67 |
$271.63 |
| 72082 |
|
24 |
24 |
$262.93 |
| 82397 |
|
25 |
25 |
$255.51 |
| 89051 |
|
167 |
152 |
$253.29 |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
62 |
62 |
$244.70 |
| 86644 |
|
27 |
27 |
$231.10 |
| 86645 |
|
37 |
37 |
$230.71 |
| 72202 |
|
25 |
25 |
$229.56 |
| 86015 |
|
39 |
39 |
$224.26 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,063 |
9,117 |
$220.07 |
| 96131 |
|
72 |
72 |
$219.94 |
| 90698 |
|
591 |
591 |
$217.11 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
12 |
12 |
$216.56 |
| 89050 |
|
135 |
123 |
$212.21 |
| 73521 |
|
38 |
38 |
$210.52 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
6,020 |
5,797 |
$206.07 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
9,164 |
8,261 |
$200.61 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,349 |
1,928 |
$194.52 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
46 |
46 |
$194.08 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
336 |
322 |
$185.92 |
| 90744 |
|
248 |
248 |
$184.74 |
| 86707 |
|
12 |
12 |
$169.83 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
252 |
245 |
$167.78 |
| 84132 |
|
137 |
123 |
$167.16 |
| A9270 |
Non-covered item or service |
142 |
82 |
$163.45 |
| 88313 |
|
42 |
29 |
$154.73 |
| 91321 |
|
41 |
41 |
$145.92 |
| 82040 |
|
46 |
42 |
$140.04 |
| 82270 |
|
197 |
192 |
$139.18 |
| 82232 |
|
14 |
13 |
$139.01 |
| 99156 |
|
155 |
154 |
$135.98 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
19 |
13 |
$135.20 |
| 82668 |
|
12 |
12 |
$121.13 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
696 |
566 |
$110.13 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,443 |
923 |
$105.38 |
| 83883 |
|
13 |
12 |
$105.00 |
| 82360 |
|
17 |
16 |
$102.89 |
| C2625 |
Stent, non-coronary, temporary, with delivery system |
26 |
24 |
$97.34 |
| 94727 |
|
12 |
12 |
$94.66 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
825 |
536 |
$89.46 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,353 |
2,138 |
$85.34 |
| C1788 |
Port, indwelling (implantable) |
27 |
27 |
$84.67 |
| A4648 |
Tissue marker, implantable, any type, each |
486 |
466 |
$84.15 |
| 82365 |
|
31 |
26 |
$83.74 |
| J1953 |
Injection, levetiracetam, 10 mg |
177 |
149 |
$76.50 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
405 |
275 |
$73.62 |
| 80178 |
|
13 |
12 |
$69.58 |
| 88302 |
|
15 |
14 |
$64.25 |
| 82310 |
|
13 |
12 |
$62.21 |
| 84295 |
|
48 |
39 |
$61.95 |
| 86593 |
|
41 |
41 |
$61.59 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
923 |
727 |
$57.72 |
| J1644 |
Injection, heparin sodium, per 1000 units |
991 |
518 |
$57.65 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
629 |
615 |
$57.24 |
| 70360 |
|
13 |
13 |
$53.16 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
55 |
50 |
$49.22 |
| C9113 |
Injection, pantoprazole sodium, per vial |
394 |
268 |
$43.73 |
| 84520 |
|
14 |
14 |
$43.11 |
| 96127 |
|
605 |
598 |
$40.66 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,367 |
1,152 |
$39.03 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,510 |
2,030 |
$38.37 |
| 73000 |
|
13 |
13 |
$38.17 |
| J3480 |
Injection, potassium chloride, per 2 meq |
311 |
235 |
$37.20 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
457 |
403 |
$33.92 |
| 84157 |
|
69 |
66 |
$32.12 |
| J9260 |
Injection, methotrexate sodium, 50 mg |
14 |
12 |
$29.99 |
| J3360 |
Injection, diazepam, up to 5 mg |
71 |
61 |
$29.54 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
1,175 |
1,078 |
$26.99 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
358 |
328 |
$26.41 |
| 85347 |
|
13 |
12 |
$25.06 |
| 73600 |
|
29 |
28 |
$22.46 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
620 |
470 |
$20.69 |
| 82945 |
|
41 |
39 |
$19.77 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
13 |
13 |
$18.57 |
| C2627 |
Catheter, suprapubic/cystoscopic |
28 |
28 |
$17.85 |
| J7510 |
Prednisolone oral, per 5 mg |
379 |
298 |
$17.59 |
| J1790 |
Injection, droperidol, up to 5 mg |
211 |
188 |
$17.40 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
27 |
26 |
$16.30 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
303 |
222 |
$15.26 |
| J1940 |
Injection, furosemide, up to 20 mg |
137 |
107 |
$14.94 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
750 |
672 |
$14.36 |
| J3371 |
Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg |
60 |
56 |
$10.10 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
109 |
104 |
$7.31 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
326 |
265 |
$4.32 |
| J2060 |
Injection, lorazepam, 2 mg |
587 |
461 |
$3.14 |
| J1836 |
Injection, metronidazole, 10 mg |
47 |
36 |
$3.00 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
101 |
98 |
$0.96 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
13 |
13 |
$0.33 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
456 |
430 |
$0.18 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
296 |
293 |
$0.04 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
28 |
28 |
$0.03 |
| 90473 |
|
30 |
30 |
$0.00 |
| 99221 |
|
15 |
14 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
76 |
75 |
$0.00 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
156 |
151 |
$0.00 |
| C1758 |
Catheter, ureteral |
29 |
28 |
$0.00 |
| J0290 |
Injection, ampicillin sodium, 500 mg |
16 |
12 |
$0.00 |
| D9230 |
Inhalation of nitrous oxide / analgesia, anxiolysis |
12 |
12 |
$0.00 |
| 0353U |
|
17 |
17 |
$0.00 |
| 96159 |
|
15 |
12 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
25 |
25 |
$0.00 |
| D1208 |
Topical application of fluoride, excluding varnish |
2,548 |
2,548 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
286 |
285 |
$0.00 |
| 99417 |
Prolong home eval add 15m |
148 |
141 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
183 |
170 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
49 |
37 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
73 |
66 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
80 |
44 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
13 |
13 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
20 |
20 |
$0.00 |